Abstracts deadline Friday 24 April 2026! Submit now

d
h
m
s

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s
Days
Hrs
Mins

Dr Michael Tee

Michael L. Tee, MD, is a rheumatologist and academic leader who serves as Chancellor of the University of the Philippines Manila, the national health sciences center. A clinician-scientist, he is regarded as one of the country’s foremost contributors to genetics research in rheumatology, with work focused on elucidating the genetic and immunologic underpinnings of systemic lupus erythematosus and other autoimmune rheumatic diseases. His research integrates molecular genetics, epidemiology, and outcomes science to better understand ethnic susceptibility, disease expression, and treatment response among Asian populations.
Dr. Tee is also a member of the Asia Pacific Lupus Collaboration (APLC), advancing multicenter studies, harmonized regional data platforms, and context-responsive recommendations for lupus care. Through sustained collaboration, he is strengthening research capacity and is fostering cross-border partnerships addressing disparities in diagnosis and access to therapy.
His scholarship bridges bench, bedside, and policy—advocating precision medicine, equitable access to immunomodulatory treatments, and evidence-informed strategies to improve the lives of patients with rheumatic diseases.

Michael L. Tee, MD, is a rheumatologist and academic leader who serves as Chancellor of the University of the Philippines Manila, the national health sciences center. A clinician-scientist, he is regarded as one of the country’s foremost contributors to genetics research in rheumatology, with work focused on elucidating the genetic and immunologic underpinnings of systemic lupus erythematosus and other autoimmune rheumatic diseases. His research integrates molecular genetics, epidemiology, and outcomes science to better understand ethnic susceptibility, disease expression, and treatment response among Asian populations. Dr. Tee is also a member of the Asia Pacific Lupus Collaboration (APLC), advancing multicenter studies, harmonized regional data platforms, and context-responsive recommendations for lupus care. Through sustained collaboration, he is strengthening research capacity and is fostering cross-border partnerships addressing disparities in diagnosis and access to therapy. His scholarship bridges bench, bedside, and policy—advocating precision medicine, equitable access to immunomodulatory treatments, and evidence-informed strategies to improve the lives of patients with rheumatic diseases.

Sessions

Presentations

Share

Key dates

Registrations
Abstracts

More speakers

Prof Susanna Proudman
Royal Adelaide Hospital, Australia
Dr. Anindita Santosa
Aaria Rheumatology, Singapore
Prof Gulen Hatemi
Istanbul University - Cerrahpasa. Turkiye
Prof Andrea Doria
Professor Of Rheumatology And Senior Scientist, University Of Padua. Italy
Dr. Ho-Youn Kim
Catholic University of Korea, Republic of Korea
Prof. Rachelle Buchbinder
Monash University, Australia
Days
Hours
Minutes
Seconds
Until 11:59PM AEST Tuesday 23 June, 2026

The countdown is on

Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.

Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.